Enanta Pharmaceuticals, Inc. (ENTA) Balance Sheet
As of 2026-06-30 (10-Q), Enanta Pharmaceuticals, Inc. (ENTA) reported total assets of $296.9M, total liabilities of $195.8M and shareholders' equity of $101.1M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $33.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ENTAEnanta Pharmaceuticals, Inc.Follow ENTA — free
—
Price chart with a free account
- Market cap
- 339.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
| Line | FY2013 Sep 13 | FY2014 Sep 14 | FY2015 Sep 15 | FY2016 Sep 16 | FY2017 Sep 17 | FY2018 Sep 18 | FY2019 Sep 19 | FY2020 Sep 20 | FY2021 Sep 21 | FY2022 Sep 22 | FY2023 Sep 23 | FY2024 Sep 24 | FY2025 Sep 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 8.9 | 30.7 | 21.7 | 16.6 | 65.7 | 63.9 | 51.2 | 87.1 | 57.2 | 44.0 | 85.4 | 37.2 | 32.3 | 33.4 | |
| Short-term investments | 92.6 | 60.1 | 123.5 | 193.5 | 158.0 | 244.8 | 284.0 | 299.5 | 186.8 | 205.2 | 284.5 | 211.0 | 156.6 | 156.1 | |
| Receivables | 0.8 | 1.7 | 15.3 | 12.8 | 10.6 | 67.2 | 51.3 | 23.5 | 23.6 | 20.3 | 8.6 | 6.6 | 6.9 | 6.5 | |
| Current assets | 104.7 | 108.0 | 170.6 | 232.2 | 237.8 | 380.4 | 401.8 | 436.8 | 319.0 | 311.7 | 422.8 | 299.9 | 204.3 | 203.6 | |
| Total assets | 117.0 | 155.4 | 246.0 | 281.3 | 326.6 | 414.2 | 489.8 | 486.1 | 438.8 | 375.4 | 462.3 | 376.7 | 280.7 | 296.9 | |
| Current liabilities | 4.5 | 4.7 | 6.7 | 7.9 | 21.0 | 16.0 | 22.6 | 24.2 | 36.2 | 29.8 | 62.8 | 57.5 | 48.6 | 54.2 | |
| Total liabilities | 6.5 | 6.8 | 9.9 | 11.3 | 25.0 | 20.5 | 27.3 | 30.6 | 39.4 | 54.1 | 245.5 | 247.8 | 216.0 | 195.8 | |
| Shareholders' equity | 110.5 | 148.7 | 236.2 | 269.9 | 301.7 | 393.7 | 462.5 | 455.6 | 399.4 | 321.3 | 216.7 | 128.8 | 64.7 | 101.1 |
USD millions · SEC XBRL
Enanta Pharmaceuticals, Inc. — questions
- How much cash does Enanta Pharmaceuticals, Inc. have?
- $33.4M in cash and cash equivalents as of 2026-06-30.
- What are Enanta Pharmaceuticals, Inc.'s total assets?
- $296.9M as of 2026-06-30.
- What is Enanta Pharmaceuticals, Inc.'s shareholders' equity?
- $101.1M as of 2026-06-30.
Every figure on this page comes from Enanta Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.